NCT04205409
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +46 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Clinical trial condition
Refractory Mantle Cell Lymphoma
Explore clinical trials studying Refractory Mantle Cell Lymphoma. Study availability and eligibility vary by location and protocol.
41 public trials
8 recruiting studies
Refractory Mantle Cell Lymphoma trial results
NCT04703686
- Conditions
- Diffuse Large B-cell Lymphoma Refractory, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- CHU Amiens Picardie Site sud Amiens, France
- CHU de Clermont Ferrand Clermont-Ferrand, France
- Hopital Henri Mondor Créteil, France
- CHU de Dijon - Hôpital le Bocage Dijon, France
NCT02568553
- Conditions
- Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +53 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- UC San Diego Moores Cancer Center La Jolla, California, United States
- Los Angeles General Medical Center Los Angeles, California, United States
NCT04578600
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +39 more
- Locations
-
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
NCT03440567
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +14 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
NCT04872413
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT03206970
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Beijing Cancer Hospital Beijing, Beijing Municipality, China
- Fujian Medical University Union Hospital Fuzhou, Fujian, China
- Nanfang Hospital of Southern Medical University Guangzhou, Guangdong, China
- Henan Cancer Hospital Zhengzhou, Henan, China
Completed
Phase I/Ib Study of Nivolumab & Veliparib in Patients With Advanced Solid Tumors & Lymphoma
NCT03061188
- Conditions
- Advanced Solid Neoplasm, Aggressive Non-Hodgkin Lymphoma, Hemic and Lymphatic Diseases, +14 more
- Locations
-
- Northwestern University Chicago, Illinois, United States
Completed
Ibrutinib in Treating Patients With Refractory or Relapsed Lymphoma After Donor Stem Cell Transplant
NCT02869633
- Conditions
- Blastoid Variant Mantle Cell Lymphoma, Chronic Disease, Disease Attributes, +27 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Stanford Cancer Institute Palo Alto, California, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
NCT03219047
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States